Results 241 to 250 of about 936,037 (347)

Correction to: Serum levels of sclerostin reflect altered bone microarchitecture in patients with hepatic cirrhosis. [PDF]

Wien Klin Wochenschr, 2020
Wakolbinger R, Muschitz C, Wallwitz J, Bodlaj G, Feichtinger X, Schanda JE, Resch H, Baierl A, Pietschmann P.   +8 more
europepmc   +1 more source

Management of Satellite Lesions in Hepatocellular Carcinoma: An Updated Review

Journal of Surgical Oncology, EarlyView.
ABSTRACT Satellite lesions, defined as microscopic or small macroscopic tumor nodules within 2 cm of a primary hepatocellular carcinoma (HCC), represent early intrahepatic dissemination and are strongly associated with aggressive tumor biology.
Andy Tran, Mohammed O. Suraju, Ihuoma Tasie, Abdelrahman K. Abdalla, Hassan Aziz   +4 more
wiley   +1 more source

Severe Complications After Splenic Artery Embolization for Portal Hypertension Due to Hepatic Cirrhosis. [PDF]

Risk Manag Healthc Policy, 2020
Zhang L, Zhang ZG, Long X, Liu FL, Zhang WG.   +4 more
europepmc   +1 more source

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.

New England Journal of Medicine, 1996
Nrico, Egalia, Alvatore, Ndreola, ndrea, Ulvirenti, ederico, Ozzetti, Abrizio, Ontalto, lberto, Orabito, Eandro, Ennari   +13 more
semanticscholar   +1 more source

Deresuscitation Informed by Ultrasound in Patients with Septic Shock Trial

Journal of Ultrasound in Medicine, EarlyView.
Objectives The venous excess ultrasound (VExUS) can be used at the point‐of‐care to identify venous overload and end‐organ congestion in an effort to individually tailor resuscitation and deresuscitation in patients with septic shock. Methods We conducted a pilot randomized controlled feasibility trial of VExUS‐guided fluid management in adult patients
Brendan Innes, Christopher Allison, Nicholas Seidler, Burton Shen, Andrew Fried, Gary Phillips, Andrew Levinson, Adeel Abbasi   +7 more
wiley   +1 more source

Hepatic cirrhosis

, 2009
Victor J. Navarro, Simona Rossi, Steven K. Herrine   +2 more
openaire   +2 more sources

Hepatoprotective activity of Lactéol® forte and quercetin dihydrate against thioacetamide-induced hepatic cirrhosis in male albino rats. [PDF]

J Cell Mol Med
Saad HM, Oda SS, Alexiou A, Papadakis M, Mahmoud MH, Batiha GE, Khalifa E.   +6 more
europepmc   +1 more source

Splenectomy with Portoazygous Disconnection for Correction of Systemic Hemodynamic Disorders in Hepatic Cirrhosis Patients with Portal Hypertension: A Prospective Single-Center Cohort Study. [PDF]

Can J Gastroenterol Hepatol, 2020
Zeng DB, Di L, Guo QL, Ding J, Zhao XF, Lu SC.   +5 more
europepmc   +1 more source

Admission Plasma Lipopolysaccharide‐binding protein, Procalcitonin, and Lactate for Early Identification of Nosocomial Infection in Cirrhotic Patients With Upper Gastrointestinal Bleeding: A Retrospective Analysis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT This study aimed to assess whether admission plasma lipopolysaccharide‐binding protein (LBP), procalcitonin (PCT), and lactate could improve detection of nosocomial infection in cirrhotic patients presenting with upper gastrointestinal bleeding (UGIB).
Li Chen, Shan‐Shan Dun, Fang Xiao
wiley   +1 more source

Hepatic Cirrhosis: A Literature Review

Hepatic cirrhosis is a chronic liver disease characterized by fibrosis and regeneration of nodules in the liver, which if it occurs for a long time, hepatocyte cells will be damaged so that they cannot function again, potentially threatening life.
Abida, Aisya Nur, Dewi, Komang Puspa, Aunurrahman, Muhammad Rezky Audia, Aswandani, Alifa, Husna, Najla Firyal, Shofa, Dhiya Atsila, Anggraeni, Baiq Annisa Ulfi   +6 more
core   +1 more source